Amplify Amplify your take on things.  Join Mike Pearson on Amplify

Legal ICT clippings

Things I Amplify from the web
« Amplog Home   Posts tagged: patents

About this Amplog

I am an ICT strategist who scans hundreds of articles from web sources around the world each week. If you’re not so keen on all that reading, but you do want to be informed about ICT trends and issues that might affect your future, then subscribe to my InfoClip service.

This Amplog is a sample of recent Legal ICT articles from my InfoClip service. View other samples:



Contact me if you would like a free 1 month trial.

Contributors to this Amplog

Mike Pearson

Nokia sues Apple for patent infringement

Not unexpected as Apple’s share of the smartphone market is increasing at the expense of Nokia.  It does highlight the importance of patents in a market.

Amplify’d from www.stuff.co.nz

Nokia sues Apple for patent infringement

The world’s top cellphone maker Nokia has accused Apple of infringing Nokia patents in its iPhone.

Nokia dominates the global handset market but it has lost some ground to new smartphone entrants like Apple which entered the market with its iPhone in mid-2007.

The patents cover wireless data, speech coding, security and encryption and are infringed by all Apple iPhone models shipped since the iPhone was introduced in 2007, Nokia said.

“By refusing to agree appropriate terms for Nokia’s intellectual property, Apple is attempting to get a free ride on the back of Nokia’s innovation,” Ilkka Rahnasto, Vice President for Legal & Intellectual Property at Nokia, said in a statement.

Read more at www.stuff.co.nz
 

Should your genes be open source?

No Commentary

Amplify’d from healthcare.zdnet.com

Should your genes be open source?

Brian Ahier writes at his Healthcare IT blog that about 3 million genome-related patents are now on file, suggesting this could slow the development of tests and cures. So far the National Research Council disagrees. A draft report from the National Insitutes of Health indicates 20% of the human genome is already patented.

The issue of genetic patenting is also being examined in Australia, where a Senate committee will soon hold public hearings on the question of genetic patents. This came after Genetic Technologies Ltd., which licensed the Australian rights to Myriad’s patent, send lawyer letters to everyone conducting tests for the BRCA1 and BRCA2 genes, telling them to cease and desist.

The arguments should be familiar to everyone involved in controversies involving software patents and open source. Are patent rights on genes necessary to innovation, or are they in fact a hindrance?

Read more at healthcare.zdnet.com